Aging, Addiction, Attention Deficit Disorder With Hyperactivity, Sleep Disorders, Anxiety, Depression, Attention Deficit
Conditions
Brief summary
The objective of this research is to develop original virtual reality scenarios and/or new virtual reality equipments to evaluate or diagnose pathologies, such as attention deficit disorders or neuropsychiatric pathologies, addiction, anxiety or depression or pathologies interfering with sleep/wake disorders.
Detailed description
Nature of the trial: without direct individual benefit study conducted in healthy volunteers, patients with attention disorders : ADHD (Attention Deficit Disorder / Hyperactivity) and cognitive aging, addictive disorders, anxiety disorders, depressive disorders or pathologies that interfere with sleep/wake cycle. The duration of the study is 8 years. Type of trial: Comparison of two parallel groups of healthy volunteers and patients with attention disorders, addictive, anxious, depressive or interfering with sleep/wake cycle. Study design: * standardized clinical interview with a sleep specialist, psychiatrist, or psychologist and rating scales, * a virtual reality task. The primary outcome is to evaluate the diagnosis accuracy and the acceptability of the virtual tool to the referent standard (clinical interview and scales). The secondary outcomes are: * The comparison of healthy subjects and patients performances * Tolerance, acceptability to exposure to virtual scenarios.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Being aged between 7 and 75 years * Having signed written informed consent
Exclusion criteria
* Having participated to a clinical trial in the previous 3 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Presence or absence of the disease | 1 day | Categorial diagnosis generated by the psychiatrist and by the Virtual reality task (0=absence of disease and 1 = presence of the disease) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Sleepiness scale | 1 day | Scores range from 0 (no sleepiness) to 24 (severe sleepiness) |
| BDI-II questionnaire | 1 day | Beck Depression Inventory Scores range from 0 (no depression) to 63 (severe depression) |
| IDS-R questionnaire | 1 day | Inventory of Depressive Symptomatology scores range from 0 (no depression) to 84 (severe depression) |
| Acceptability scale | 1 day | Scores range from 0 to 36 |
| ASRS | 1 day | Adult ADHD Self-Report Scale Scores : Four or more positive answers in Part A (6 questions) are indicative of ADHD symptoms. |
| Physiological parameters: Polysomnography (total sleep time (min)) | 1 night | — |
| Physiological parameters: Polysomnography (sleep structure (stage %)) | 1 night | — |
| Physiological parameters: Polysomnography (Apnea/Hypopnea index and Periodic movements index (events/hr)) | 1 night | — |
Countries
France